Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Edwards Lifesciences (EW) Deferred Taxes (2016 - 2026)

Edwards Lifesciences has reported Deferred Taxes over the past 17 years, most recently at $54.4 million for Q4 2025.

For Q4 2025, Deferred Taxes fell 44.77% year-over-year to $54.4 million; the TTM value through Dec 2025 reached $117.6 million, down 63.64%, while the annual FY2025 figure was $117.6 million, 63.64% down from the prior year.
Deferred Taxes for Q4 2025 was $54.4 million at Edwards Lifesciences, up from $18.0 million in the prior quarter.
Over five years, Deferred Taxes peaked at $123.0 million in Q3 2024 and troughed at -$10.8 million in Q1 2021.
A 5-year average of $50.4 million and a median of $49.0 million in 2022 define the central range for Deferred Taxes.
Biggest five-year swings in Deferred Taxes: crashed 200.0% in 2021 and later soared 1287.18% in 2022.
Year by year, Deferred Taxes stood at $61.5 million in 2021, then surged by 72.03% to $105.8 million in 2022, then decreased by 13.61% to $91.4 million in 2023, then increased by 7.77% to $98.5 million in 2024, then crashed by 44.77% to $54.4 million in 2025.
Business Quant data shows Deferred Taxes for EW at $54.4 million in Q4 2025, $18.0 million in Q3 2025, and $20.9 million in Q2 2025.